IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
lamiVUDine-zidovudine
lamiVUDine-zidovudine
Brand names:
Combivir
Form
Strength
TABLET, ORAL
150 mg-300 mg
Display
HIV Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Class:
08180820
Medication comments:
USP <800> Hazardous Drugs
Policy
NIOSH 2016
View all
Per Policy, these drugs have special handling requirements (any drug with an "AOR" is exempt from these requirements under normal circumstances).
generic (Brand)
Route
Risk Level
AOR?
Warnings
(hover over entry for details)
lamiVUDine-zidovudine (Combivir)
PO
Medium
No
IARC-2B
FDA-C
Receiving
• Gloves:
Single
Pharmacy:
Preparation
• Gloves: ---
• Gown: ---
• Ventilated Engineering controls: ---
• Closed System Transfer Device: ---
Nursing:
Administration
• Gloves:
Single: (Intact Tablets or Capsules); Double: (Oral Liquid or Tube Feeding)
• Gown:
Yes, (Oral Liquid or Tube Feeding)
• Eye/face protection:
Yes, if potential vomit or spit up
• Closed System Transfer Device: ---
Last updated:
Apr. 17, 2020
Hazard.Drug Handling(USP 800)
USP<800> Hazardous Drug
Black Box Warnings
lamiVUDine: Lactic acidosis, hepatomegaly; exacerbations of hepatitis b; dosing formulation
Black Box Warnings
Zidovudine: Hematological adverse events; myopathy; lactic acidosis; hepatomegaly
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(hover over entry for details)
Preparation
Administration